Gameto, a $73 million-backed biotech startup, has received FDA Investigational New Drug clearance for Fertilo, their innovative IVF treatment. This milestone enables the company to initiate Phase 3 clinical trials in the United States, marking a significant step toward potentially offering a more affordable and less invasive fertility treatment option.